EN
We strive to make patients-driven cellular immunotherapy innovation,
to transform cancer into a manageable condition — and ultimately cure it.
 
HomeNews and MediaIndustry Trends
Industry Trends
  • 11.122021
    Expert opinions:Arming cytotoxic lymphocytes for cancer immunotherapy by means of the NKG2D/NKG2D ligand system
  • 07.272021
    U.S. Life Science Top 10 Market Trends for 2021
1
More

Copyright © 2019 TCR CURE Biopharma Technology Co., Ltd Powered by vancheer
About TCRCure
Research and Development
Product and Cinical trial
News and Media

Copyright © 2019 TCR CURE Biopharma Technology Co., Ltd Powered by vancheer